Results 251 to 260 of about 109,974 (359)

Health Policy Newsletter March 2007 Vol. 20, No. 1 [PDF]

, 2008

core   +1 more source

Lessons in uncertainty and humility — Clinical trials involving hypertension [PDF]

, 2016
McMurray, John J.V., Pfeffer, Marc A.
core   +1 more source

Correlation between time in range and mild cognitive impairment in older adults with type 2 diabetes mellitus

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims To investigate the association between time in range (TIR) and mild cognitive impairment (MCI) in older adult patients with type 2 diabetes mellitus (T2DM) and the contributions of various indicators to MCI. Materials and Methods Two hundred and three participants received continuous glucose monitoring and cognitive assessments.
Jiajun Bao, Tianhong Xu, Ting Gu, Yi Sun, Yilan Jiang, Jing Xiao, Yunjuan Gu   +6 more
wiley   +1 more source

Anionic lipopeptides from Bacillus mojavensis I4 as effective antihypertensive agents: Production, characterization, and identification. [PDF]

Eng Life Sci, 2017
Ghazala I, Bouassida M, Krichen F, Manuel Benito J, Ellouz-Chaabouni S, Haddar A.   +5 more
europepmc   +1 more source

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial (RESOLUTION study)

Journal of Diabetes Investigation, EarlyView.
Luseogliflozin alleviated renal function decline (eGFR) after an initial decrease, showing renoprotective effects in patients with renal impairment. Luseogliflozin did not increase renal events, showing safety even in patients with moderate‐to‐severe renal impairment.
Munehiro Kitada, Masao Toyoda, Osamu Sekine, Daisuke Suzuki, Yosuke Okada, Yoshikata Morita, Hideki Nishimura, Hiroaki Satoh, Hideki Kamiya, Toshinari Takamura, Motohide Isono, Takeshi Onoue, Hiroshi Arima, Kenichi Tanaka, Masaji Miyamoto, Yasushi Omura, Daisuke Yabe, Takehiro Kato, Akimichi Asano, Yutaka Wakasa, Satoshi Miyamoto, Shinji Kume, Tomohiko Ito, Shin‐ichi Araki, Atsushi Nakagawa, RESOLUTION Study Investigators   +25 more
wiley   +1 more source

Impact of Mental Disorders on the Association Between Adherence to Antihypertensive Agents and All-Cause Healthcare Costs. [PDF]

J Clin Hypertens (Greenwich), 2017
Gentil L, Vasiliadis HM, Préville M, Berbiche D.   +3 more
europepmc   +1 more source

Relationship between antihypertensive agents and prolonged bleeding time in patients with end-stage renal failure.

, 2002
Kôichi Hayashi, Hiroto Matsuda, Masanori Honda, Takeshi Kanda, Koichiro Homma, Hiroo Kumagai, Takao Saruta   +6 more
openalex   +2 more sources

SCORE2‐Older Persons (SCORE2‐OP): Validation and Added Value of Excessive Daytime Sleepiness in a French Cohort

Journal of the American Geriatrics Society, EarlyView.
External validation of SCORE2‐OP in older French adults and incremental value of excessive daytime sleepiness for cardiovascular risk prediction: SCORE2‐OP showed moderate discrimination and overestimated risk by 25%. Adding EDS did not improve overall model performance but enhanced classification in low‐ and intermediate‐risk groups.
Tahiana Andriambelosoa, Clémence Cavaillès, Jean‐Philippe Empana, Thibault Mura, Catherine Helmer, Yves Dauvilliers, Isabelle Jaussent   +6 more
wiley   +1 more source

Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis. [PDF]

Br J Clin Pharmacol, 2014
Dial S, Nessim SJ, Kezouh A, Benisty J, Suissa S.   +4 more
europepmc   +1 more source

On the Utilization of Antihypertensive and Antibacterial Agents

, 2002
Koichi Nobutomo, Yasuhiro Kitazoe, Takao Orii, Hiroyuki Satoh, Kikuo Arakawa, Tetsuro Matsumoto, Joichi Kumazawa, Taro Shuin   +7 more
openalex   +2 more sources